• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

改善难民和移民获得耐多药结核病诊断和卫生服务的机会。

Improving access to multi-drug resistant tuberculosis diagnostic and health services for refugees and migrants.

机构信息

Division of Infection and Immunity, Centre for Clinical Microbiology, University College London, London, UK.

NIHR Biomedical Research Centre, University College London Hospitals NHS Foundation Trust, London, UK.

出版信息

BMC Med. 2018 Nov 30;16(1):221. doi: 10.1186/s12916-018-1218-0.

DOI:10.1186/s12916-018-1218-0
PMID:30497477
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6267830/
Abstract

By the end of 2017, an estimated 68.5 million people were displaced from their homes worldwide, of whom 25.4 million were refugees. The transmission and globalization of multi-drug resistant tuberculosis during refugee migration is a now priority issue in the public health agenda. Political and scientific commitment at the highest national and international levels will be critical to intensifying action in promoting improved health services for migrants and refugees.

摘要

截至 2017 年底,全球估计有 6850 万人被迫离开家园,其中 2540 万人是难民。在难民迁徙过程中,耐多药结核病的传播和全球化是当前公共卫生议程上的一个优先事项。在国家和国际最高层面上的政治和科学承诺,对于加强行动以促进改善移民和难民的卫生服务至关重要。

相似文献

1
Improving access to multi-drug resistant tuberculosis diagnostic and health services for refugees and migrants.改善难民和移民获得耐多药结核病诊断和卫生服务的机会。
BMC Med. 2018 Nov 30;16(1):221. doi: 10.1186/s12916-018-1218-0.
2
Access to free or low-cost tuberculosis treatment for migrants and refugees along the Thailand-Myanmar border in Tak province, Thailand.泰国夜丰颂府泰国-缅甸边境沿线的移民和难民可获得免费或低成本的结核病治疗。
Int J Equity Health. 2016 Jul 7;15(1):100. doi: 10.1186/s12939-016-0391-z.
3
Migrant and Refugee Patient Perspectives on Travel and Tuberculosis along the Thailand-Myanmar Border: A Qualitative Study.泰国-缅甸边境地区移民和难民患者对旅行与结核病的看法:一项定性研究
PLoS One. 2016 Aug 10;11(8):e0160222. doi: 10.1371/journal.pone.0160222. eCollection 2016.
4
Family planning rarely available for refugees.难民很少能获得计划生育服务。
Netw Res Triangle Park N C. 1995 Mar;15(3):4-8.
5
Research Needs on Respiratory Health in Migrant and Refugee Populations. An Official American Thoracic Society and European Respiratory Society Workshop Report.移民和难民人群呼吸健康研究需求。美国胸科学会和欧洲呼吸学会官方研讨会报告。
Ann Am Thorac Soc. 2018 Nov;15(11):1247-1255. doi: 10.1513/AnnalsATS.201807-478ST.
6
International refugees: a geographical perspective.国际难民:地理视角
J Geog. 1987 Sep-Oct;86(5):225-8. doi: 10.1080/00221348708979490.
7
Universal health coverage for refugees and migrants in the twenty-first century.二十一世纪难民和移民的全民健康覆盖。
BMC Med. 2018 Nov 26;16(1):216. doi: 10.1186/s12916-018-1208-2.
8
COVID-19: Marking the Gaps in Migrant and Refugee Health in Some Massive Migration Areas.新冠疫情:凸显部分大规模移民地区移民和难民健康方面的差距。
Int J Environ Res Public Health. 2021 Nov 30;18(23):12639. doi: 10.3390/ijerph182312639.
9
The future of refugee flows and policies.难民流动与政策的未来。
Int Migr Rev. 1992 Winter;26(4):1,112-43.
10
European policies in the management of tuberculosis among migrants.欧洲在移民结核病管理方面的政策。
Int J Infect Dis. 2017 Mar;56:85-89. doi: 10.1016/j.ijid.2016.11.002. Epub 2016 Nov 9.

引用本文的文献

1
The unmet surgical needs of global refugee populations: A perspective review.全球难民群体未得到满足的外科手术需求:一篇综述
SAGE Open Med. 2023 Oct 10;11:20503121231204492. doi: 10.1177/20503121231204492. eCollection 2023.
2
Facilitators and barriers to tuberculosis active case findings in low- and middle-income countries: a systematic review of qualitative research.中低收入国家结核病主动发现的促进因素和障碍:定性研究的系统评价。
BMC Infect Dis. 2023 Aug 7;23(1):515. doi: 10.1186/s12879-023-08502-7.
3
Patient-centered approach to the management of drug-resistant tuberculosis in France: How far off the mark are we?法国以患者为中心的耐多药结核病管理方法:我们偏离目标有多远?
PLOS Glob Public Health. 2022 Apr 20;2(4):e0000313. doi: 10.1371/journal.pgph.0000313. eCollection 2022.
4
Catch-22: War, Refugees, COVID-19, and the Scourge of Antimicrobial Resistance.第二十二条军规:战争、难民、新冠疫情与抗微生物药物耐药性的祸害
Front Med (Lausanne). 2022 Jun 24;9:921921. doi: 10.3389/fmed.2022.921921. eCollection 2022.
5
Influence of Public Health Services on the Goal of Ending Tuberculosis: Evidence From Panel Data in China.公共卫生服务对终结结核病目标的影响:来自中国面板数据的证据。
Front Public Health. 2022 Mar 4;10:826800. doi: 10.3389/fpubh.2022.826800. eCollection 2022.
6
Is deployement of diagnostic test alone enough? Comprehensive package of interventions to strengthen TB laboratory network: three years of experience in Burkina Faso.仅部署诊断检测是否足够?加强结核实验室网络的综合干预包:布基纳法索的三年经验。
BMC Infect Dis. 2021 Apr 13;21(1):346. doi: 10.1186/s12879-021-06012-y.
7
Policy changes and the screening, diagnosis and treatment of drug-resistant tuberculosis patients from 2015 to 2018 in Zhejiang Province, China: a retrospective cohort study.中国浙江省2015年至2018年耐药结核病患者的政策变化及筛查、诊断与治疗:一项回顾性队列研究
BMJ Open. 2021 Apr 12;11(4):e047023. doi: 10.1136/bmjopen-2020-047023.

本文引用的文献

1
The historic and unprecedented United Nations General Assembly High Level Meeting on Tuberculosis (UNGA-HLM-TB)-'United to End TB: An Urgent Global Response to a Global Epidemic'.具有历史意义且史无前例的联合国大会结核病问题高级别会议——“联合终结结核病:对全球流行病的紧急全球应对” 。
Int J Infect Dis. 2018 Oct;75:118-120. doi: 10.1016/j.ijid.2018.09.017. Epub 2018 Sep 19.
2
Antimicrobial resistance among migrants in Europe: a systematic review and meta-analysis.欧洲移民中的抗菌药物耐药性:系统评价和荟萃分析。
Lancet Infect Dis. 2018 Jul;18(7):796-811. doi: 10.1016/S1473-3099(18)30219-6. Epub 2018 May 17.
3
Migration and tuberculosis transmission in a middle-income country: a cross-sectional study in a central area of São Paulo, Brazil.中低收入国家的人口迁移与结核病传播:巴西圣保罗中心地区的一项横断面研究。
BMC Med. 2018 Apr 30;16(1):62. doi: 10.1186/s12916-018-1055-1.
4
Global spread of antibiotic-resistant bacteria and mass-gathering religious events.抗生素耐药细菌的全球传播与大型宗教活动
Lancet Infect Dis. 2018 May;18(5):488-490. doi: 10.1016/S1473-3099(18)30242-1.
5
Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies.结核病:新药、治疗方案和宿主导向治疗的开发进展和进展。
Lancet Infect Dis. 2018 Jul;18(7):e183-e198. doi: 10.1016/S1473-3099(18)30110-5. Epub 2018 Mar 23.
6
Multidrug-resistant tuberculosis treatment adherence in migrants: a systematic review and meta-analysis.移民人群中耐多药结核病治疗依从性:系统评价和荟萃分析。
BMC Med. 2018 Feb 22;16(1):27. doi: 10.1186/s12916-017-1001-7.
7
Tuberculosis in migrants in low-incidence countries: epidemiology and intervention entry points.低发病率国家移民中的结核病:流行病学与干预切入点
Int J Tuberc Lung Dis. 2017 Jun 1;21(6):624-637. doi: 10.5588/ijtld.16.0845.
8
An overview of tuberculosis and migration.结核病与移民概述
Int J Tuberc Lung Dis. 2017 Jun 1;21(6):610-623. doi: 10.5588/ijtld.16.0917.
9
Ending tuberculosis in risk groups in Europe: challenges from travel and population movement.欧洲风险群体中结核病的终结:旅行与人口流动带来的挑战。
Euro Surveill. 2017 Mar 23;22(12). doi: 10.2807/1560-7917.ES.2017.22.12.30489.
10
Multidrug-resistant tuberculosis and migration to Europe.耐多药结核病与欧洲移民
Clin Microbiol Infect. 2017 Mar;23(3):141-146. doi: 10.1016/j.cmi.2016.09.009. Epub 2016 Sep 23.